Abstract
Stress urinary incontinence (SUI) has a reported prevalence between 12.8 and 46 %. There is no doubt that SUI has been shown to negatively impact the everyday quality of life (QOL) of the women who suffer from this dysfunction. The economic burden for the treatment of urinary incontinence has been estimated to be approximately 19 billion annually in the United States. Risk factors for the development of SUI include age, obesity, previous pelvic surgery, and childbirth. Surgical management of SUI is the standard of care once conservative options, such as behavioral modification, pelvic floor exercises, fluids modification, and scheduled voiding, have been exhausted. The surgical options have evolved over the last few decades to include the Burch colposuspension, periurethral bulking agents, pubovaginal slings, and the newest multitude of approaches for midurethral synthetic slings. The synthetic slings include retropubic, transobturator, and the newest additions which include the so-called single-incision slings. The aims of this chapter include the evaluation and management of SUI and review each of the surgical techniques currently available to pelvic floor surgeons.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Botlero R, Urquhart DM, Davis SR, Bell RJ. Prevalence and incidence of urinary incontinence in women: review of the literature and investigation of methodological issues. Int J Urol. 2008;15(3):230–4.
Coyne KS, Zhou Z, Thompson C, Versi E. The impact on health-related quality of life of stress, urge and mixed urinary incontinence. BJU Int. 2003;92(7):731–5.
Hu TW, Wagner TH, Bentkover JD, Leblanc K, Zhou SZ, Hunt T. Costs of urinary incontinence and overactive bladder in the United States: a comparative study. Urology. 2004;63(3):461–5.
Ogah J, Cody JD, Rogerson L. Minimally invasive synthetic suburethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev. 2009;4, CD006375.
Abrams P, Andersson KE, Birder L, et al. Fourth international consultation on incontinence recommendations of the international scientific committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn. 2010;29(1):213–40.
Leach GE, Dmochowski RR, Appell RA, et al. Female stress urinary incontinence clinical guidelines panel summary report on surgical management of female stress urinary incontinence. The American Urological Association. J Urol. 1997;158(3 Pt 1):875–80.
BURCH JC. Urethrovaginal fixation to cooper’s ligament for correction of stress incontinence, cystocele, and prolapse. Am J Obstet Gynecol. 1961;81:281–90.
Tanagho EA. Colpocystourethropexy: the way we do it. J Urol. 1976;116(6):751–3.
Lapitan MC, Cody JD. Open retropubic colposuspension for urinary incontinence in women. Cochrane Database Syst Rev. 2012;6, CD002912.
Sivaslioglu AA, Unlubilgin E, Keskin HL, Gelisen O, Dolen I. The management of recurrent cases after the burch colposuspension: 7 years experience. Arch Gynecol Obstet. 2011;283(4):787–90.
Walter AJ, Morse AN, Hammer RA, et al. Laparoscopic versus open burch retropubic urethropexy: comparison of morbidity and costs when performed with concurrent vaginal prolapse repairs. Am J Obstet Gynecol. 2002;186(4):723–8.
Demirci F, Petri E. Perioperative complications of Burch colposuspension. Int Urogynecol J Pelvic Floor Dysfunct. 2000;11(3):170–5.
Stanton SL, Cardozo LD. Results of the colposuspension operation for incontinence and prolapse. Br J Obstet Gynaecol. 1979;86(9):693–7.
Langer R, Lipshitz Y, Halperin R, Pansky M, Bukovsky I, Sherman D. Long-term (10-15 years) follow-up after Burch colposuspension for urinary stress incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2001;12(5):323–6. discussion 326-7.
Alcalay M, Monga A, Stanton SL. Burch colposuspension: a 10-20 year follow up. Br J Obstet Gynaecol. 1995;102(9):740–5.
Wiskind AK, Creighton SM, Stanton SL. The incidence of genital prolapse after the Burch colposuspension. Am J Obstet Gynecol. 1992;167(2):399–404. discussion 404-5.
McGuire EJ, Cespedes RD, O'Connell HE. Leak-point pressures. Urol Clin North Am. 1996;23(2):253–62.
Rovner ES, Ginsberg DA, Raz S. Why anti-incontinence surgery succeeds or fails. Clin Obstet Gynecol. 1998;41(3):719–34.
Pannek J, Brands FH, Senge T. Particle migration after transurethral injection of carbon coated beads for stress urinary incontinence. J Urol. 2001;166(4):1350–3.
Lightner D, Calvosa C, Andersen R, et al. A new injectable bulking agent for treatment of stress urinary incontinence: results of a multicenter, randomized, controlled, double-blind study of durasphere. Urology. 2001;58(1):12–5.
Mayer R, Lightfoot M, Jung I. Preliminary evaluation of calcium hydroxylapatite as a transurethral bulking agent for stress urinary incontinence. Urology. 2001;57(3):434–8.
ter Meulen PH, Berghmans LC, van Kerrebroeck PE. Systematic review: efficacy of silicone microimplants (Macroplastique) therapy for stress urinary incontinence in adult women. Eur Urol. 2003;44(5):573–82.
Madjar S, Sharma AK, Waltzer WC, Frischer Z, Secrest CL. Periurethral mass formations following bulking agent injection for the treatment of urinary incontinence. J Urol. 2006;175(4):1408–10.
Lai HH, Hurtado EA, Appell RA. Large urethral prolapse formation after calcium hydroxylapatite (coaptite) injection. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(9):1315–7.
Albo ME, Litman HJ, Richter HE, et al. Treatment success of retropubic and transobturator mid urethral slings at 24 months. J Urol. 2012;188(6):2281–7.
Welk BK, Herschorn S. The autologous fascia pubovaginal sling for complicated female stress incontinence. Can Urol Assoc J. 2012;6(1):36–40.
Gomelsky A, Dmochowski RR. Bladder neck pubovaginal slings. Expert Rev Med Devices. 2005;2(3):327–40.
Ulmsten U, Henriksson L, Johnson P, Varhos G. An ambulatory surgical procedure under local anesthesia for treatment of female urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 1996;7(2):81–5. discussion 85-6.
Fong ED, Nitti VW. Review article: Mid-urethral synthetic slings for female stress urinary incontinence. BJU Int. 2010;106(5):596–608.
Petros PP, Ulmsten U. An anatomical classification–a new paradigm for management of female lower urinary tract dysfunction. Eur J Obstet Gynecol Reprod Biol. 1998;80(1):87–94.
Novara G, Artibani W, Barber MD, et al. Updated systematic review and meta-analysis of the comparative data on colposuspensions, pubovaginal slings, and midurethral tapes in the surgical treatment of female stress urinary incontinence. Eur Urol. 2010;58(2):218–38.
Kenton K, Stoddard AM, Zyczynski H et al. 5-year Logitudinal follow-up after retropbubic and transobturator midurethral slings. J Urol. 2014 Aug 23 (Epub ahead of print).
Morton HC, Hilton P. Urethral injury associated with minimally invasive mid-urethral sling procedures for the treatment of stress urinary incontinence: A case series and systematic literature search. BJOG. 2009;116(8):1120–6.
Cornu JN, Lizee D, Sebe P, et al. TVT SECUR single-incision sling after 5 years of follow-up: the promises made and the promises broken. Eur Urol. 2012;62(4):737–8.
Kennelly MJ, Moore R, Nguyen JN, Lukban JC, Siegel S. Prospective evaluation of a single incision sling for stress urinary incontinence. J Urol. 2010;184(2):604–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Chuang, KW., Firoozi, F. (2015). Surgical Management of Stress Urinary Incontinence. In: Firoozi, F. (eds) Female Pelvic Surgery. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1504-0_3
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1504-0_3
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1503-3
Online ISBN: 978-1-4939-1504-0
eBook Packages: MedicineMedicine (R0)